Moneyview IPO Day 4: GMP ₹0

Alright folks, it’s Day 4 of the Moneyview IPO subscription period, and we’re here to give you the lowdown on how things are shaping up. The IPO, which opened its doors on September 24th and is set to close on September 28th, is offering shares at an issue price of ₹34. As we head into the final stretch, the subscription numbers are… well, let’s dive in and see what they tell us.

Subscription Status

As of Day 4, it’s interesting to note that the subscription figures across all categories remain at 0x. This means that not a single share has been subscribed for by Retail individual investors, High Net-worth Individuals (HNIs), or Qualified Institutional Buyers (QIBs). Zero subscriptions across the board can be a bit of a head-scratcher, especially as the IPO is nearing its closing date. Typically, by Day 4, we’d expect to see some level of interest, even if it’s modest. The absence of any subscription in the Retail category is particularly noteworthy, as this segment usually drives initial demand for many mainboard IPOs. Similarly, the 0x subscription for HNIs and QIBs suggests a cautious approach or perhaps a wait-and-watch strategy from larger investors. It’s not necessarily a red flag yet, but it’s certainly something to keep an eye on as the remaining days unfold. The lot size for this IPO is 441 shares, so these 0x figures represent a complete lack of commitment from all investor types so far.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Moneyview IPO is standing at ₹0. This is unchanged from yesterday’s figures, which also showed a ₹0 GMP. A GMP of ₹0 essentially means that the market is not willing to pay any premium over the issue price of ₹34. In simpler terms, the expected listing price is currently hovering right around the issue price itself, at ₹34. While a ₹0 GMP isn’t ideal, it also doesn’t necessarily spell disaster. It indicates that there’s no speculative demand pushing the price higher in the unofficial market. For investors, this means that the primary attraction of this IPO might not be the prospect of immediate listing gains, but rather the company’s long-term fundamentals and growth potential.

Should You Apply?

So, the million-dollar question: should you be applying for the Moneyview IPO? The current subscription data, showing zero interest from all investor categories, coupled with a ₹0 GMP, paints a picture of extreme caution or perhaps indifference from the market at this moment. This is a scenario that warrants careful consideration. Typically, a healthy subscription level, especially in the NII and QIB segments, and a positive GMP are strong indicators of market appetite. However, the absence of both is a bit unusual. It’s crucial to remember that SEBI registered investment advisors often emphasize the importance of thorough due diligence beyond just subscription numbers and GMP. You’ll want to examine Moneyview’s business model, financial health, future prospects, and the competitive landscape. If you’re an investor looking for quick listing gains, this IPO might not be your cup of tea given the current sentiment. If, on the other hand, you believe in the company’s long-term vision and its potential to grow, then the current lack of hype might even present an opportunity to get in at a fair valuation. Do your homework, consult with your financial advisor, and make an informed decision.

View Full Moneyview IPO Details